Market Cap 489.79M
Revenue (ttm) 23.61M
Net Income (ttm) -105.51M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 17.34
Profit Margin -446.89%
Debt to Equity Ratio 0.46
Volume 394,100
Avg Vol 910,806
Day's Range N/A - N/A
Shares Out 56.30M
Stochastic %K 89%
Beta 0.99
Analysts Strong Sell
Price Target $22.86

Company Profile

Zevra Therapeutics, Inc., a commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States. The company develops its products through Ligand Activated Technology platform. Its lead product candidate is KP1077, consisting of KP1077IH, which is under Phase 2 clinical trial for the treatment of idiopathic hypersomnia, and KP1077N, which is under Phase 1/2 clinical trial to treat narcolepsy. The company is also developing Celiprolol, a prodrug pro...

Industry: Biotechnology
Sector: Healthcare
Phone: 321 939 3416
Website: zevra.com
Address:
1180 Celebration Boulevard, Suite 103, Celebration, United States
Pomer_Gile1
Pomer_Gile1 Feb. 25 at 12:35 PM
1 · Reply
EthanStawk
EthanStawk Feb. 25 at 9:07 AM
$ZVRA There's nothing here except flipping and waiting with your core position. The fact is, as much as these shaved gibbons can try to fuck it up (and now that laduane isn't doing the math on a graphing calculator from his high school days that he just used to play Snake or drug dealer on) the revenue is going to be substantial, and EU approval ultimately doubles it. The lawsuit is a mosquito on an elephants ass, and we did bring in some competent people. The same rationale that brought me here for Azstarys applies now, and corium can eat an entire bag of dicks on that one. Best medicine in existence for ADHD, could have done real good, but fuck em. The trajectory is pretty definited at this point as long as Neil ignores every single instinct he has except to sell in under 3 years.
2 · Reply
ekoostik16
ekoostik16 Feb. 25 at 2:56 AM
$ZVRA 3k march 9s and March 10 & $11 calls seen small volume today. Success is tied to Q4 Earnings, unless a surprise catalyst happens.
0 · Reply
PencilNeckGeek
PencilNeckGeek Feb. 24 at 9:01 PM
$ZVRA Wow, almost $9. This is a rocket 🚀🚀🚀
0 · Reply
XL10
XL10 Feb. 24 at 8:43 PM
0 · Reply
InvestorRelations_
InvestorRelations_ Feb. 24 at 5:56 PM
$ZVRA are we getting rid off this cancer in ~6 months?
3 · Reply
KemPharm_rocks
KemPharm_rocks Feb. 24 at 4:54 PM
$ZVRA How y’all doin’?
1 · Reply
lance1965
lance1965 Feb. 24 at 1:58 PM
0 · Reply
Cube_CH
Cube_CH Feb. 24 at 1:11 PM
0 · Reply
DevAd
DevAd Feb. 24 at 9:52 AM
0 · Reply
Latest News on ZVRA
Zevra Therapeutics, Inc. Announces CFO Transition

Nov 20, 2025, 4:05 PM EST - 3 months ago

Zevra Therapeutics, Inc. Announces CFO Transition


Zevra Therapeutics, Inc. (ZVRA) Q2 2025 Earnings Call Transcript

Aug 12, 2025, 8:43 PM EDT - 7 months ago

Zevra Therapeutics, Inc. (ZVRA) Q2 2025 Earnings Call Transcript


Zevra Therapeutics, Inc. (ZVRA) Q1 2025 Earnings Call Transcript

May 13, 2025, 10:45 PM EDT - 10 months ago

Zevra Therapeutics, Inc. (ZVRA) Q1 2025 Earnings Call Transcript


Zevra Therapeutics Files Preliminary Proxy

Mar 31, 2025, 4:12 PM EDT - 11 months ago

Zevra Therapeutics Files Preliminary Proxy


Zevra to Participate at Upcoming Investor Conferences

Feb 24, 2025, 4:02 PM EST - 1 year ago

Zevra to Participate at Upcoming Investor Conferences


Zevra Therapeutics Announces Organizational Changes

Dec 6, 2024, 5:00 PM EST - 1 year ago

Zevra Therapeutics Announces Organizational Changes


Pomer_Gile1
Pomer_Gile1 Feb. 25 at 12:35 PM
1 · Reply
EthanStawk
EthanStawk Feb. 25 at 9:07 AM
$ZVRA There's nothing here except flipping and waiting with your core position. The fact is, as much as these shaved gibbons can try to fuck it up (and now that laduane isn't doing the math on a graphing calculator from his high school days that he just used to play Snake or drug dealer on) the revenue is going to be substantial, and EU approval ultimately doubles it. The lawsuit is a mosquito on an elephants ass, and we did bring in some competent people. The same rationale that brought me here for Azstarys applies now, and corium can eat an entire bag of dicks on that one. Best medicine in existence for ADHD, could have done real good, but fuck em. The trajectory is pretty definited at this point as long as Neil ignores every single instinct he has except to sell in under 3 years.
2 · Reply
ekoostik16
ekoostik16 Feb. 25 at 2:56 AM
$ZVRA 3k march 9s and March 10 & $11 calls seen small volume today. Success is tied to Q4 Earnings, unless a surprise catalyst happens.
0 · Reply
PencilNeckGeek
PencilNeckGeek Feb. 24 at 9:01 PM
$ZVRA Wow, almost $9. This is a rocket 🚀🚀🚀
0 · Reply
XL10
XL10 Feb. 24 at 8:43 PM
0 · Reply
InvestorRelations_
InvestorRelations_ Feb. 24 at 5:56 PM
$ZVRA are we getting rid off this cancer in ~6 months?
3 · Reply
KemPharm_rocks
KemPharm_rocks Feb. 24 at 4:54 PM
$ZVRA How y’all doin’?
1 · Reply
lance1965
lance1965 Feb. 24 at 1:58 PM
0 · Reply
Cube_CH
Cube_CH Feb. 24 at 1:11 PM
0 · Reply
DevAd
DevAd Feb. 24 at 9:52 AM
0 · Reply
ZVRA100
ZVRA100 Feb. 23 at 9:37 PM
$ZVRA tomorrow Z may announce the Q4 2025 earnings call date.
2 · Reply
Smedley1
Smedley1 Feb. 23 at 9:10 PM
$ZVRA some way, some how…get this thing to $25
2 · Reply
WaynD01
WaynD01 Feb. 23 at 5:28 PM
$ZVRA I have reached my target on ZVRA accumulation and I am in the wait and see mode now. But , just in case, if the market brings an opportuntity I will add 20-25% more to it. But I am happy with what I have now.
1 · Reply
Pentium
Pentium Feb. 23 at 5:00 PM
$ZVRA Waiting patiently for some stupidity odds are Neil tanks ER again with some foolishness and I’ll be ready to add more and go from 200k-250k shares if low 8s or high 7s are seen.
2 · Reply
pissripper59
pissripper59 Feb. 23 at 4:16 PM
$ZVRA i have owned this stock for 5 years im down over 4000 dollars . Now thats a pissripper.
2 · Reply
lance1965
lance1965 Feb. 23 at 2:08 PM
0 · Reply
EthanStawk
EthanStawk Feb. 23 at 1:59 PM
$ZVRA Zebras main focus is shifting to treating people special needs... Mainly in the boardroom. Treating them to bullshit compensation packages for eating crayons and licking the walls.
0 · Reply
BMW2002
BMW2002 Feb. 23 at 10:05 AM
0 · Reply
dogfish90ipa
dogfish90ipa Feb. 21 at 11:45 PM
$ZVRA i was gonna wait till April Fools day, but I think I'm just gonna move on and swap into IBRX.
3 · Reply
JamesLeague540
JamesLeague540 Feb. 21 at 8:24 AM
$ZVRA Zevra Therapeutics focuses on rare diseases. Clinical execution drives valuation. Commercial ramp is key.
1 · Reply
WaynD01
WaynD01 Feb. 20 at 9:42 PM
$ZVRA Still I wont recommend buying ZVRA calls. I bought becuase I got it cheap and the odds are much better this time to print.
0 · Reply
WaynD01
WaynD01 Feb. 20 at 9:33 PM
$ZVRA So all my Feb calls I sold expired worthless and in the bank now as all other past expirations. Interestingly, I have bought a lots of March calls after a long time, in fact, the first serious buy after Miplyffa Adcom/Approval.
0 · Reply